Clinical Trials · NCT01591902
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- Theratechnologies
- Enrollment
- 129
- Start date
- Jun 2012
- Locations
- 24 sites, United States
- Primary endpoint
- Difference in percentages of subjects with a 3-step or greater progression (from both eyes) on the Early Treatment Diabetic Retinopathy Study (ETDRS) PERSON scale.